Oct 03, 2024 Draft regulation on therapeutic use of cannabis in Spain By Elisa Lorenzo The Spanish Ministry of Health has made public this week the draft Royal Decree establishing the conditions for the elaboration and...
Dec 06, 2021 The importance of regional innovation hubs in supporting the UK's Life Sciences Vision By Lyndsey Hudson Following on from my recent comments about the UK being a viable location to be a life sciences startup - with the right governmental...
Oct 23, 2020 Digital Therapeutics - evolution and entry into mainstream healthcare By Dr Kokularajah Paheenthararajah This international report on "Digital Therapeutics - Evolution and entry into mainstream healthcare" was recently published jointly by...
Apr 23, 2020 Clinical trials during the COVID-19 pandemic: A global guide By Dr Kokularajah Paheenthararajah After weeks of intensive collaboration and inspiring contributions from more than 100 Life Sciences enthusiasts across five continents,...
Jan 24, 2020 New transparency obligations for medical device companies in Italy By Mark Franklin Nicola Landolfi On 1 January 2021, important transparency obligations provided for in the Code of Ethics of Confindustria Dispositivi Medici (the Italian...
Jan 10, 2020 German govt. introduces prescription healthcare apps and opens fast-track pathway to reimbursement By Dr Kokularajah Paheenthararajah The new German Digital Healthcare Act (Digitale‑Versorgung‑Gesetz/DVG), among many other groundbreaking changes, enables any physician or...
Nov 10, 2017 Medical devices and the smartphone's growing influence By DLA Piper Like many, I love finding out about how technology is shaping our lives and changing society. Deloitte's new research on smartphones...
Nov 02, 2017 Extending patent protection for life science companies By DLA Piper How far does the new doctrine of equivalents introduced by the UK Supreme Court in Eli Lilly v Actavis really extend the scope of patent...
Oct 26, 2017 The impact of Brexit on regulation in the life sciences sector By DLA Piper The House of Lords Science and Technology Committee's inquiry into "Life Sciences and the Industrial Strategy" is fascinating. Last week...
Oct 18, 2017 Transforming business IP creation and protection By DLA Piper In a fascinating talk by Dr Stephan Wolke CEO of Thyssenkrupp at the C5 Life Sciences Summit in Munich last week, Dr Wolke shared his...